Yesterday, Cancer Research UK
press released the launch of the first full version of
canSAR - the
Institute of Cancer Research's integrated cancer research and drug discovery resource. canSAR integrates large volumes of disparate data covering most aspects of cancer biology and chemistry, and is an example of how to complement the chEMBL database with therapeutic area specific knowledge. canSAR integrates biological annotation, gene expression, RNA interference studies, structural biology and protein interaction network data - as well as chemical and pharmacological data. It contains annotation on the entire human proteome, and contains >8 million experimental data points including RNAi and chemical screening data. For full release notes please see
canSAR news. canSAR is updated monthly. As well as the wonderful chEMBL, the data in canSAR comes from a large number of sources, including
ArrayExpress,
PDBe,
ROCK,
STRING,
Genomics of Drug Sensitivity in Cancer,
COSMIC,
BindingDB,
SCOP,
PFAM- we (at the ICR) are grateful to our friends at all these places for their help. In the new year, we will be holding a series of webinars and walkthroughs, and details of these will be posted on the ChEMBL-og.
